Trade

with

Cambrex Corp
(NYSE: CBM)
AdChoices
=
18.10
0.00
0.00%
After Hours :
-
-
-

Open

18.17

Previous Close

18.10

Volume (Avg)

220.79k (262.19k)

Day's Range

18.03-18.17

52Wk Range

15.20-23.88

Market Cap.

555.31M

Dividend Rate ( Yield )

-

Beta

0.69

Shares Outstanding

30.68M

P/E Ratio (EPS)

15.36 (1.06)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 318.18M

    • Net Income

    • 25.92M

    • Market Cap.

    • 555.31M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 9.61

    • PEG (Price/Earnings Growth) Ratio

    • 1.72

    • Beta

    • 0.69

    • Forward P/E

    • 14.03

    • Price/Sales

    • 1.64

    • Price/Book Value

    • 2.36

    • Price/Cash flow

    • 12.79

      • EBITDA

      • 72.10M

      • Return on Capital %

      • 7.27

      • Return on Equity %

      • 16.06

      • Return on Assets %

      • 7.27

      • Book Value/Share

      • 7.68

      • Shares Outstanding

      • 30.68M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.03 (1/31/2007)

      • Dividend Declaration Date

      • 1/26/2007

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 27.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -

        • Cashflow Estimate

        • 2.05

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 56.70

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -52.10

          • 17.04

          • Net Income

            Q/Q (last year)

          • 532.20

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 5.01

          • 63.43

          • Net Income

            5-Year Annual Average

          • 30.70

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 31.61

            • 82.75

            • Pre-Tax Margin

            • 10.79

            • 39.38

            • Net Profit Margin

            • 9.61

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 30.70

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 9.90

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • 8.70

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.31

              • 0.76

              • Current Ratio

              • 2.17

              • 2.92

              • Quick Ratio

              • 1.03

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 2.02

              • 2.21

              • Book Value/Share

              • 7.68

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 15.06

                • 243.90

                • P/E Ratio 5-Year High

                • 20.27

                • 634.30

                • P/E Ratio 5-Year Low

                • 2.42

                • 124.82

                • Price/Sales Ratio

                • 1.60

                • 9.29

                • Price/Book Value

                • 2.31

                • 8.39

                • Price/Cash Flow Ratio

                • 12.79

                • 49.75

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 16.06

                    (18.50)

                  • 37.63

                    (27.20)

                  • Return on Assets %

                    (5-Year Average)

                  • 7.27

                    (6.40)

                  • 17.22

                    (13.81)

                  • Return on Capital %

                    (5-Year Average)

                  • 11.55

                    (11.00)

                  • 21.78

                    (17.31)

                  • Income/Employee

                  • 35.39k

                  • 117.08k

                  • Inventory Turnover

                  • 2.36

                  • 1.48

                  • Asset Turnover

                  • 0.76

                  • 0.55

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  49.63M
                  Operating Margin
                  15.60
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  12.79
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  37.91%

                  Mutual Fund Ownership

                  46.28%

                  Float

                  87.40%

                  5% / Insider Ownership

                  3.94%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Heartland Value Fund

                  •  

                    1,000,000

                  • -6.23

                  • 3.26

                  • Walthausen Small Cap Value Fund

                  •  

                    660,134

                  • 23.84

                  • 2.15

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    620,257

                  • 0.57

                  • 1.93

                  • Vanguard Total Stock Mkt Idx

                  •  

                    474,662

                  • 0.55

                  • 1.55

                  • iShares Russell 2000 (AU)

                  •  

                    460,592

                  • -1.80

                  • 1.43

                  • Trans Small Cap Growth Fund

                  •  

                    451,136

                  • 53.45

                  • 1.47

                  • Loomis Sayles Small Cap Growth Fund

                  •  

                    390,741

                  • -3.58

                  • 1.27

                  • TIAA-CREF Small-Cap Equity

                  •  

                    317,055

                  • 41.70

                  • 1.03

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    305,602

                  • 0.00

                  • 1.00

                  • Vanguard Extended Market Index Fund

                  •  

                    295,176

                  • 0.74

                  • 0.96

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • BlackRock Fund Advisors

                  •  

                    1,636,211

                  • -5.23%

                  • 5.33

                  • Ranger Investment Management, L.P.

                  •  

                    1,428,792

                  • +47.67%

                  • 4.66

                  • Dimensional Fund Advisors, Inc.

                  •  

                    1,385,844

                  • +6.31%

                  • 4.52

                  • Acadian Asset Management LLC

                  •  

                    1,214,548

                  • +0.68%

                  • 3.96

                  • Vanguard Group, Inc.

                  •  

                    1,152,574

                  • +2.15%

                  • 3.76

                  • Penn Capital Management CO Inc

                  •  

                    1,100,662

                  • -16.93%

                  • 3.59

                  • Heartland Advisors, Inc.

                  •  

                    1,000,000

                  • -6.23%

                  • 3.26

                  • Silvercrest Asset Management Group LLC

                  •  

                    970,854

                  • +4.61%

                  • 3.16

                  • Thompson, Siegel & Walmsley LLC

                  •  

                    877,598

                  • -0.19%

                  • 2.86

                  • Walthausen & Co., LLC

                  •  

                    862,304

                  • +23.29%

                  • 2.81

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Biotechnology

                  Type

                  Aggressive Growth

                  Style

                  Small Core

                  Cambrex Corp was incorporated as a Delaware corporation in 1981 and began business in December 1981. It is a life sciences company that provides products and services that accelerate and improve the development and commercialization ...moreof new and generic therapeutics. The Company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Company has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment. The Company participates in markets that serve the healthcare industry. Customers include generic drug companies and companies that discover and commercialize new small molecule human therapeutics using organic chemistry. The Company uses its technical expertise in a wide range of chemical proce...moresses to meet the needs of its customers for high quality products and services for specialized applications. The Company’s business is primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to innovator and generic drug companies. Products include APIs, pharmaceutical intermediates and, to a lesser extent, other fine chemicals. The Company’s products and services are sold to a diverse group of several hundred customers, with one customer, Gilead Sciences, Inc. The manufacturing of pharmaceutical products is subject to extensive regulation by governmental authorities, including the FDA, the European Medicines Agency and comparable regulatory authorities in other countries.lessless

                  Key People

                  Steven M. Klosk

                  CEO/Director/President

                  Shlomo Yanai

                  Director/Chairman of the Board

                  Gregory P. Sargen

                  CFO/Executive VP

                  Aldo Magnini

                  Managing Director, Subsidiary

                  Mr. Shawn P. Cavanagh

                  COO/Executive VP

                  • Cambrex Corp

                  • One Meadowlands Plaza

                  • East Rutherford, NJ 07073

                  • USA.Map

                  • Phone: +1 201 804-3000

                  • Fax: +1 201 804-9852

                  • cambrex.com

                  Incorporated

                  1981

                  Employees

                  936

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: